Patrizia Giannoni

Cerebrovascular pathology during the progression of experimental Alzheimer's disease

Patrizia Giannoni, Margarita Arango-Lievano, Ines das Neves et al. · Neurobiology of Disease · 2016 · 146 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Serotonin: A New Hope in Alzheimer’s Disease?

Sylvie Claeysen, Joël Bockaert, Patrizia Giannoni · ACS Chemical Neuroscience · 2015 · 125 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Cédric Lecoutey, Damien Hédou, Thomas Fréret et al. · Proceedings of the National Academy of Sciences · 2014 · 119 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT₄R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride

Christophe Rochais, Cédric Lecoutey, Florence Gaven et al. · Journal of Medicinal Chemistry · 2015 · 117 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain

Silvia Fossati, Patrizia Giannoni, María E. Solesio et al. · Neurobiology of Disease · 2015 · 106 citations · Full text

Medicine, Neuroscience, Pharmacology +16